Researchers: CAF Is Looking for YOUR Great Thalassemia-Related Project

October 23, 2013 – Medical researchers who are interested in initiating a thalassemia-related project or who have an existing project that requries additional funding:  The Cooley’s Anemia Foundation may be just what you need.  CAF is now accepting applications for its 2014-2015 Fellowship and Research Grant programs and we encourage you to apply.

at work
CAF has a decades-long history of supporting innovative and important research in thalassemia.  Our established and respected Medical Fellowship program has funded numerous early career individuals who have continued to stay in the thalassemia field and make important contributions to the scientific and clinical study of thalassemia.  Our Support for Ongoing Clinical Research in Thalassemia Grants and Clinical Trials in Thalassemia Cell and GeneTherapy Grants are aggressively pushing forward the understanding of issues of concern to the growing thalassemia population and helping to propel advances in areas of primary importance.

More information on each award opportunity and links to complete applications for each award follow:


SUPPORT FOR ONGOING CLINICAL RESEARCH IN THALASSEMIA

The Cooley’s Anemia Foundation invites national and international applications for 2014-2015 grants to support ongoing clinical research projects in Thalassemia. The goal of this initiative is to support investigators from all disciplines and backgrounds (MD, RN, PhD, MPH, MSW or other disciplines) with their ongoing clinical projects to address one or more of the following areas impacting patients with thalassemia: including but not limited to fertility, pregnancy and family planning; quality of life/psychosocial; burden of disease, cardiac issues and iron overload.

BoyThe stipend will be $40,000 annually with possibility of one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. This level of funding would be appropriate for support of innovative small-scale pilot studies, observational trials, or ancillary support for ongoing interventional studies (for example support of a trainee joining an existing trial, or new biological endpoint analyses for an existing trial). In the case of ancillary studies, investigators should clearly document the support for the parent trial in their “other support” declarations.

Junior and senior faculty are eligible; fellows and trainees are not eligible. Investigators must interact directly with patients or patient-related data.  Awards will be announced in June 2014.

Click here to download an application for the Support for Ongoing Research in Thalassemia grant.

The completed application is due Monday February 3, 2014.

Grant awards will be announced in June, 2014.



CLINICAL TRIALS IN THALASSEMIA CELL AND GENE THERAPY GRANT AWARD

The Cooley’s Anemia Foundation invites national and international applications for 2014-2015 grants to support ongoing clinical research projects in Thalassemia. BG

The purpose of this initiative is to speed the application of recent translational advances in gene therapy to clinical trials.  The Foundation recognizes that there are many key areas worthy of support in the search for a cure for thalassemia with cell therapy and gene therapy.  While several funding mechanisms are available for a range of studies on vector development, proof of concept studies in animal models, and transplantation, there remains a funding gap for launching human trials.  Both phase I (safety) and phase II (efficacy) trials are eligible for support.

Funding and candidate eligibility: Total funding of up to $60,000 per year will be available (including indirect costs of 8%). With satisfactory evidence of progress the grant may be renewed for a second year.

The research may not be conducted at a for-profit laboratory.

Because the purpose of the support is to facilitate launch of clinical trials, eligible studies proposed for this RFA must be accompanied by a realistic timeline of progress to human trials. The Foundation recognizes that this timeline can be long.  Applicants should state explicitly the status of their proposed trials, for example whether the trial has been approved by the recombinant DNA Advisory Committee (RAC), or Food and Drug Administration (or equivalent processes at non-US sites), or whether review meetings at regulatory agencies have been scheduled.

Awards will be announced in June 2014.

Click here to download an application for the Clinical Trials in Thalassemia Cell and Gene Therapy Grant Award.

The completed application is due Monday February 3, 2014.


RESEARCH FELLOWSHIPS

dishThe Cooley’s Anemia Foundation invites national and international applications for 2014-2015 Research Fellowships.

Postdoctoral and junior faculty members investigating clinical or basic research related to thalassemia are eligible.  Applications studying iron overload, iron chelation, methods of non-invasive iron measurement, quality of life, hepatitis C, osteoporosis, fertility, bone marrow transplantation and gene therapy are encouraged.  Postdoctoral fellows should hold MD, PhD or equivalent degrees and require sponsorship by a faculty mentor. Junior faculty applicants should not have held the rank of Assistant Professor for more than 5 years and must not have already received R-01 level support.

Stipends will be $32,500 annually with possibility of a one year renewal upon submission of a renewal application and approval by the Foundation’s Scientific Review Committee and Board of Directors. Successful postdoctoral fellows are expected to use the funds for salary support, whereas junior faculty applicants may use funds for salary or non-salary research support. Awards will be announced in June 2014.

Click here to download an application for Research Fellowships.

The completed application is due Monday, February 3, 2014.

A scanned completed application in PDF format for each application is to be e-mailed to: info@thalassemia.org

For further information, please contact:

Cooley’s Anemia Foundation

330 Seventh Avenue #200

New York, NY 10001

800 522 7222

info@thalassemia.org

 

 

If you enjoyed this post, please consider leaving a comment or subscribing to the RSS feed to have future articles delivered to your feed reader.